GDTC Stock Analysis: Buy, Sell, or Hold?
GDTC - CytoMed Therapeutics Limited Ordinary Shares
$1.18
0.04 (3.51%)
▲
5d:
-1.67%
30d:
+18.36%
90d:
+11.32%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Jun 30, 2026
25d
Get Alerted When GDTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GDTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: GDTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: GDTC is currently trading at $1.18, which is considered slightly high relative to its 30-day fair value range of $0.86 to $1.20.
Technical Outlook: Technically, GDTC is showing sideways momentum. Immediate support is located at $1.11, while resistance sits at $1.35. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: GDTC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+323.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GDTC is showing sideways momentum. Immediate support is located at $1.11, while resistance sits at $1.35. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: GDTC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+323.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.86 -
$1.20
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 323.7% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$0.86 -
$1.20
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.11
Resistance Level
$1.35
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Wall Street Target
$5.00
(+323.7%)
Revenue Growth (YoY)
46.9%
Share & Embed Analysis
Last updated: June 04, 2026 5:28 AM ET
Data refreshes hourly during market hours. Next update: 6:28 AM
Data refreshes hourly during market hours. Next update: 6:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDTC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
